Jason D. Fontenot is SVP, Chief Scientific Officer of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 136,270 shares of SGMO, which is worth approximately $340,675. The most recent transaction as insider was on Nov 25, 2023, when has been sold 1,030 shares (Common Stock) at a price of $0.38 per share, resulting in proceeds of $391. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
0% 3M change
0% 12M change
Total Value Held $340,675

Jason D. Fontenot Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2023
SELL
Payment of exercise price or tax liability
$391 $0.38 p/Share
1,030 Reduced 0.75%
136,270 Common Stock
Aug 25 2023
SELL
Payment of exercise price or tax liability
$792 $0.77 p/Share
1,029 Reduced 0.74%
137,300 Common Stock
May 25 2023
SELL
Payment of exercise price or tax liability
$1,368 $1.33 p/Share
1,029 Reduced 0.74%
138,329 Common Stock
Feb 25 2023
SELL
Payment of exercise price or tax liability
$17,446 $2.66 p/Share
6,559 Reduced 4.5%
139,358 Common Stock
Feb 24 2023
BUY
Grant, award, or other acquisition
-
42,750 Added 22.66%
145,917 Common Stock
Apr 25 2022
SELL
Payment of exercise price or tax liability
$3,990 $4.83 p/Share
826 Reduced 0.79%
103,167 Common Stock
Feb 25 2022
SELL
Payment of exercise price or tax liability
$36,863 $5.9 p/Share
6,248 Reduced 9.59%
58,893 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
45,100 Added 30.25%
103,993 Common Stock
Apr 25 2021
SELL
Payment of exercise price or tax liability
$9,497 $11.71 p/Share
811 Reduced 1.28%
62,496 Common Stock
JDF

Jason D. Fontenot

SVP, Chief Scientific Officer
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO